Lumida
/ASPN
⌘K
Aspen Aerogels Inc

Aspen Aerogels Inc

ASPN
$4.91USD+3.15%+0.15 today

MARKET CAP

407.5M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$2
$9

AI Summary

Stalk
TrimMedium

ASPN remains in a Stage 4 decline with a clear sequence of lower highs and lower lows, reinforced by downward-sloping EMAs and resistance at the 50 and 200 SMAs. Medium-term bias stays bearish, and short-term execution reads as neutral with price oscillating around flat/declining EMAs below major moving averages. We defer bearish execution, looking to trim into rallies toward the 9/21 EMA and the SMA 50/200 resistance zones.

  • Q2 revenue $49.8M (+32% QoQ)
  • Q3 guidance $65–80M signals 30–60% sequential growth
  • $5.3M incident costs from East Providence plant downtime
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$121.6M$180.4M$238.7M$452.7M$271.1M
YoY %+21.3%+48.3%+32.4%+89.6%-40.1%
P / Sales12.5x2.2x4.5x2.1x0.9x
EV / Sales12.3x1.7x4.8x2.2x0.9x
Gross Profit, Adj.$9.9M$5.0M$56.9M$182.9M$46.0M
YoY %-31.9%-49.9%+1043.9%+221.3%-74.9%
Margin %8.2%2.8%23.8%40.4%17.0%
EV / Gross Profit150.3x62.7x20.0x5.5x5.4x
EBITDA, Adj.$-31.2M$-70.0M$-33.9M$80.6M$-6.2M
YoY %-174.0%-124.7%+51.6%+337.8%-107.7%
Margin %-25.6%-38.8%-14.2%17.8%-2.3%
EV / EBITDA-47.9x-4.5x-33.6x12.6x-39.7x
EBIT$-40.6M$-79.2M$-49.2M$54.5M$-360.1M
YoY %-88.2%-95.2%+37.9%+210.8%-760.2%
Margin %-33.4%-43.9%-20.6%12.0%-132.8%
EV / EBIT-36.8x-3.9x-23.2x18.6x-0.7x
Net Income$-37.1M$-82.7M$-45.8M$13.4M$-389.6M
YoY %-70.1%-123.0%+44.6%+129.2%-3012.5%
Net Margin-30.5%-45.9%-19.2%3.0%-143.7%
EPS (GAAP)-$1.22-$2.10-$0.66$0.17-$4.73
YoY %-47.0%-72.1%+68.6%+125.8%-2882.4%